These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 2508586)

  • 21. Sequential intravenous/oral ciprofloxacin as an empiric antimicrobial therapy: results of a Canadian multicenter study. The Canadian Collaborative Investigational Group.
    Davis C
    Clin Ther; 1994; 16(3):505-21. PubMed ID: 7923317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential intravenous/oral ciprofloxacin in the treatment of severe multiresistant gram-negative infections.
    Chayakul P; Krisanapan S; Kalnauwakul S
    J Med Assoc Thai; 1993 Jan; 76(1):35-40. PubMed ID: 8228692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciprofloxacin-resistant Pseudomonas keratitis.
    Garg P; Sharma S; Rao GN
    Ophthalmology; 1999 Jul; 106(7):1319-23. PubMed ID: 10406614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
    Lorian V; Pavletich K
    Drugs Exp Clin Res; 1994; 20(5):209-14. PubMed ID: 7875058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M; Velluti G
    J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of late-onset hospital-acquired pneumonia related to causative organism.
    McClure JR; Cooke RP; Lal P; Pickles D; Majjid S; Grant CA; Jones TM; Dempsey GA
    J Hosp Infect; 2009 Apr; 71(4):348-52. PubMed ID: 19157643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of ciprofloxacin and conventional therapy in the treatment of patients with chronic lower leg ulcers infected with Pseudomonas aeruginosa or other gram-negative rods.
    Valtonen V; Karppinen L; Kariniemi AL
    Scand J Infect Dis Suppl; 1989; 60():79-83. PubMed ID: 2547245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ciprofloxacin treatment in newborns with multi-drug-resistant nosocomial Pseudomonas infections.
    Belet N; Haciömeroğlu P; Küçüködük S
    Biol Neonate; 2004; 85(4):263-8. PubMed ID: 14739554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative study of nosocomial and community acquired lower respiratory tract infections. A prospective study of 232 cases].
    Huang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Dec; 13(6):342-5, 380. PubMed ID: 2128220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical efficacy and in vitro activity of the ciprofloxacin-azlocillin combination (ratio 1:10) against gram-negative bacteria from non-neutropenic haematologic patients.
    Piccolomini R; Di Girolamo A; Iacone A; Fioritoni G; Cellini L; Nicoletti M; D'Antonio D
    Drugs Exp Clin Res; 1991; 17(9):455-60. PubMed ID: 1822439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ciprofloxacin in severe infections.
    Aswapokee N; Pruksachatvuthi S; Aswapokee P
    J Med Assoc Thai; 1990 Jun; 73(6):315-20. PubMed ID: 2230626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ciprofloxacin: an alternative oral treatment in respiratory Pseudomonas infection in cystic fibrosis].
    Magni A; Pradal U; Cazzola G; Mastella G
    Pediatr Med Chir; 1990; 12(5):531-4. PubMed ID: 2087426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ciprofloxacin therapy of respiratory tract infection with Pseudomonas aeruginosa.
    Haverkorn MJ
    Eur J Clin Microbiol Infect Dis; 1988 Oct; 7(5):661-4. PubMed ID: 3143577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections.
    Hirata-Dulas CA; Stein DJ; Guay DR; Gruninger RP; Peterson PK
    J Am Geriatr Soc; 1991 Oct; 39(10):979-85. PubMed ID: 1918785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamic modeling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa.
    Hyatt JM; Schentag JJ
    Infect Control Hosp Epidemiol; 2000 Jan; 21(1 Suppl):S9-11. PubMed ID: 10654629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective randomized clinical trials of new quinolones versus beta-lactam antibiotics in lower respiratory tract infections.
    Lode H; Wiley E; Olschewski P; Sievers H; Wintermantel M; Baetz R; Lebahn K; Reinke M; Wagner J; Borner K
    Scand J Infect Dis Suppl; 1990; 68():50-5. PubMed ID: 2218423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiotic treatment of cystic fibrosis].
    de Montalembert M; Berche P; Lenoir G
    Ann Pediatr (Paris); 1991 Oct; 38(8):523-8. PubMed ID: 1746849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of pharmacokinetic parameters to efficacy of antibiotics: relationships between serum concentrations, MIC values, and bacterial eradication in patients with gram-negative pneumonia.
    Schentag JJ
    Scand J Infect Dis Suppl; 1990; 74():218-34. PubMed ID: 2097710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.